Filing Details
- Accession Number:
- 0001232524-12-000057
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-13 19:40:46
- Reporting Period:
- 2012-03-09
- Filing Date:
- 2012-03-13
- Accepted Time:
- 2012-03-13 19:40:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1512984 | J. Russell Cox | C/O Jazz Pharmaceuticals Plc 45 Fitzwilliam Square Dublin 2 L2 | Evp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2012-03-09 | 5,000 | $49.56 | 14,005 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On March 9, 2012, the Reporting Person completed the sale of 5,000 ordinary shares to Barclays Capital Inc. and Citigroup Global Markets Inc., as underwriters in connection with a public offering of a total of 7,883,366 ordinary shares by certain shareholders of the Issuer, including the Reporting Person.